Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VATS versus percutaneous pleural drain with urokinase for parapneumonic effusion in children
2014-002221-35Phase 3Completed
- Sponsor
- Queen Fabiola Children's University Hospital
- Start
- Aug 2014
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of urokinase in parapneumonic effusion, pleural effusion and bacterial disease (2 arms), sponsored by Queen Fabiola Children's University Hospital. Primary endpoint: Duration of drainage. Started Aug 2014; status: completed.
02
Drugs
urokinase
03
Conditions
parapneumonic effusionpleural effusionbacterial disease
Beyond the preview
Go deeper on 2014-002221-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002221-35.